EichorEICHOR
Location: Yuma Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Yuma

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · YUMA REGIONAL MEDICAL CENTER CANCER CENTER ( Site 0020) · Merck Sharp & Dohme LLC · NCT06077760A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Onvida Health Yuma Medical Center /ID# 253625 · AbbVie · NCT04928846A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not
Phase 3 · FIN-10401, Yuma, AZ · Colorado Prevention Center · NCT06033950Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee
Phase 3 · Anthos Investigative Site 9927 · Anthos Therapeutics, Inc. · NCT05712200Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109ALTO-100 in Bipolar Disorder With Depression (BD-D)
Phase 2 · Site 6087 · Alto Neuroscience · NCT06656416Study of ALTO-300 in MDD
Phase 2 · Site 187 · Alto Neuroscience · NCT05922878Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Phase N/A · Onvida Health Yuma Medical Center · SWOG Cancer Research Network · NCT04871542Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Phase 3 · Yuma Clinical Trials · Amgen · NCT07037459EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes,
Phase 3 · Yuma Clinical Trials · Boehringer Ingelheim · NCT07064473
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.